BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
-
* Corresponding author: Thomas Reithmeier thomas.reithmeier@uniklinik-freiburg.de
BMC Cancer 2010, 10:30 doi:10.1186/1471-2407-10-30
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 14 Mar 2009 | |
| Resubmission - Version 2 | Manuscript | 17 Mar 2009 | |
| Reviewer's Report | Antonio Silvani | 06 May 2009 | |
| Reviewer's Report | Alfredo Quinones-Hinojosa | 06 May 2009 | |
| Reviewer's Report | Renato La Rocca | 19 May 2009 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 14 Jul 2009 |
| Reviewer's Report | Antonio Silvani | 26 Aug 2009 | |
| Reviewer's Report | Renato La Rocca | 27 Aug 2009 | |
| Resubmission - Version 4 | Manuscript | Author's comment | 11 Dec 2009 |
| Editorial acceptance | 24 Dec 2009 | ||
| Published | 02 Feb 2010 |